AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Conditions: Gastric Cancer; Gastroesophageal Junction Cancer; Pancreatic Adenocarcinoma Interventions: Drug: AZD0901; Drug: 5-Fluorouracil; Drug: Leucovorin; Drug: l-leucovorin; Drug: Irinotecan; Drug: Nanoliposomal Irinotecan; Drug: Gemcitabine Sponsors: AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | AstraZeneca | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Nanotechnology | Pancreas | Pancreatic Cancer | Research